Idexx Laboratories (IDXX) Income Statement
Idexx Laboratories Income Statement
Last quarter (Q2 2026), Idexx Laboratories's total revenue was $1.22B, an increase of 9.66% from the same quarter last year. In Q2, Idexx Laboratories's net income was $338.41M. See Idexx Laboratories’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 4.30B | $ 3.90B | $ 3.66B | $ 3.37B | $ 3.22B | |
| $ 2.66B | $ 2.38B | $ 2.19B | $ 2.00B | $ 1.89B | |
| $ 1.30B | $ 1.25B | $ 1.09B | $ 1.11B | $ 957.40M | |
| Depreciation and Amortization | $ 145.18M | $ 129.94M | $ 114.91M | $ 111.90M | $ 104.60M |
| $ 1.51B | $ 1.28B | $ 1.22B | $ 1.01B | $ 1.04B | |
| $ 1.36B | $ 1.13B | $ 1.10B | $ 898.76M | $ 932.03M | |
| $ -35.84M | $ -18.51M | $ -35.95M | $ -38.79M | $ -29.37M | |
| $ 1.32B | $ 1.11B | $ 1.06B | $ 859.97M | $ 902.65M | |
| $ 1.06B | $ 887.87M | $ 845.04M | $ 679.09M | $ 744.85M | |
| Per Share Metrics | |||||
| Basic EPS | $ 13.17 | $ 10.77 | $ 10.17 | $ 8.12 | $ 8.74 |
| Diluted EPS | $ 13.08 | $ 10.67 | $ 10.06 | $ 8.03 | $ 8.60 |
| Weighted Average Shares Outstanding | 80.10M | 82.47M | 83.07M | 83.62M | 85.20M |
| Weighted Average Shares Outstanding (Diluted) | 80.67M | 83.25M | 83.98M | 84.60M | 86.57M |
Currency in USD
